Skip to main content

Veracyte, Inc.

VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001384101

In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Veracyte, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
6 insiders, $1.31M in total
Insiders trading
6
Net value
−$1.31M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Veracyte, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Veracyte, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Leite JohnGlobal Chief Commercial Off124,329Sep 22, 202610
Holstein JensDirector27,471Sep 16, 20263
Wygant JonathanVP, Chief Accounting Officer43,226Sep 4, 20268
Febbo Phillip G.Chief Scientific & Med Officer133,048Sep 4, 20267
Chambers RebeccaChief Financial Officer166,025Sep 4, 20268
McGuire AnnieEVP, General Counsel131,160Sep 4, 202611
Stapley MarcChief Executive Officer432,073Sep 4, 20267
Bhanji MunaDirector42,718Sep 3, 20262
Eastham KarinDirector15,097Jun 22, 20264
Jones Evan/ FaDirector34,634Jun 15, 20263
Epstein Robert SDirector57,718Jun 15, 20263
Shafer David BrentDirector31,100Jun 15, 20261
Barr EliavDirector56,461Jun 15, 20261
Miller Thomas F.Director31,100Jun 15, 20261
Haas Kevin RichardChief Dev and Tech Officer44,221Apr 14, 20261
Bishop John LDirector33,125Jul 19, 20230
Anderson Bonnie HDirector41,377Jun 6, 20230
Kennedy Giulia CChief Scientific & Med Officer65,970Dec 8, 20220
Gordon Kevin KDirector8,720Jun 10, 20220
Nova Tina SusanPresident, CLIA U.S.76,988Mar 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 22, 2026 (view filing)5:16 PM ETSep 211 dayLeite JohnGlobal Chief Commercial OffSSale−4.01K$40.00−$160.6K−3.1%124.3K after10b5-1
Sep 16, 2026 (view filing)4:08 PM ETSep 142 daysHolstein JensDirectorSSale−5.00K$40.95−$204.7K−15.4%27.5K after10b5-1
Sep 4, 2026 (view filing)7:54 PM ETSep 4Same dayFebbo Phillip G.Chief Scientific & Med OfficerSSale−13.1K$43.05−$564.4K−9.0%133.0K after2 lots10b5-1
Sep 4, 2026 (view filing)7:54 PM ETSep 4Same dayChambers RebeccaChief Financial OfficerSSale−3.65K$43.10−$157.4K−2.2%166.0K after2 lots10b5-1
Sep 4, 2026 (view filing)7:54 PM ETSep 4Same dayMcGuire AnnieEVP, General CounselSSale−3.25K$43.09−$140.2K−2.4%131.2K after2 lots10b5-1
Sep 3, 2026 (view filing)4:48 PM ETSep 12 daysBhanji MunaDirectorSSale−1.86K$42.97−$80.1K−4.2%42.7K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysEastham KarinDirectorSSale−3.73K$52.89−$197.2K−19.8%15.1K after2 lots10b5-1
Jun 4, 2026 (view filing)Jun 4Same dayLeite JohnGlobal Chief Commercial OffSSale−14.0K$50.07−$699.7K−9.6%132.3K after10b5-1
Jun 4, 2026 (view filing)Jun 4Same dayMcGuire AnnieEVP, General CounselSSale−3.18K$49.76−$158.0K−2.3%137.2K after2 lots10b5-1
Jun 4, 2026 (view filing)Jun 4Same dayChambers RebeccaChief Financial OfficerSSale−3.56K$49.73−$177.1K−2.0%173.3K after2 lots10b5-1
Jun 4, 2026 (view filing)Jun 4Same dayStapley MarcChief Executive OfficerSSale−138.1K$50.12−$6.92M−23.9%440.5K after10b5-1
May 27, 2026 (view filing)May 225 daysWygant JonathanVP, Chief Accounting OfficerSSale−24.0K$45.40−$1.09M−34.6%45.4K after
May 22, 2026 (view filing)May 202 daysEpstein Robert SDirectorSSale−10.0K$44.01−$440.1K−16.0%52.4K after10b5-1
May 8, 2026 (view filing)May 62 daysMcGuire AnnieSVP, General CounselSSale−10.2K$39.03−$398.2K−6.6%143.7K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 42 daysLeite JohnChief Commercial Officer-CLIASSale−5.26K$35.19−$185.1K−4.7%107.6K after10b5-1
Mar 6, 2026 (view filing)Mar 42 daysMcGuire AnnieSVP, General CounselSSale−6.66K$35.55−$236.7K−6.6%94.7K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 42 daysChambers RebeccaChief Financial OfficerSSale−18.3K$36.14−$662.9K−12.3%131.2K after2 lots10b5-1
Mar 6, 2026 (view filing)Mar 42 daysStapley MarcChief Executive OfficerSSale−45.5K$35.98−$1.64M−11.3%357.6K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 22 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−13.4K$36.16−$485.4K−10.3%117.3K after10b5-1
Dec 17, 2025 (view filing)Dec 161 dayMcGuire AnnieSVP, General CounselSSale−10.7K$43.14−$463.2K−13.7%67.8K after2 lots10b5-1
Dec 8, 2025 (view filing)Dec 53 daysEastham KarinDirectorSSale−20.0K$45.45−$909.0K−59.6%13.6K after3 lots10b5-1
Dec 4, 2025 (view filing)Dec 4Same dayLeite JohnChief Commercial Officer-CLIASSale−1.28K$47.51−$60.7K−1.5%82.1K after10b5-1
Dec 4, 2025 (view filing)Dec 4Same dayMcGuire AnnieSVP, General CounselSSale−1.42K$47.30−$67.3K−1.8%78.5K after2 lots10b5-1
Dec 4, 2025 (view filing)Dec 4Same dayChambers RebeccaChief Financial OfficerSSale−13.3K$46.84−$621.9K−10.8%109.5K after2 lots10b5-1
Dec 4, 2025 (view filing)Dec 4Same dayStapley MarcChief Executive OfficerSSale−7.67K$47.09−$361.1K−2.4%318.6K after2 lots10b5-1
Nov 26, 2025 (view filing)Nov 251 dayLeite JohnChief Commercial Officer-CLIASSale−2.81K$50.00−$140.4K−3.2%86.3K after10b5-1
Nov 26, 2025 (view filing)Nov 251 dayJones Evan/ FaDirectorSSale−1.11K$50.25−$55.6K−3.6%29.4K after10b5-1
Nov 21, 2025 (view filing)Nov 201 dayHolstein JensDirectorSSale−10.0K$42.36−$423.6K−26.9%27.2K after3 lots10b5-1
Nov 12, 2025 (view filing)Nov 7-105 daysWygant JonathanVP, Chief Accounting OfficerSSale−10.9K$41.20−$449.9K−22.0%38.7K after2 lots
Nov 7, 2025 (view filing)Nov 52 daysMcGuire AnnieSVP, General CounselSSale−6.47K$40.00−$258.6K−7.2%83.0K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysChambers RebeccaChief Financial OfficerSSale−7.00K$41.00−$287.0K−5.3%126.2K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysEastham KarinDirectorSSale−9.67K$40.02−$387.2K−41.6%13.6K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysJones Evan/ FaDirectorSSale−43.2K$45.06−$1.95M−58.6%30.5K after6 lots10b5-1
Oct 7, 2025 (view filing)Oct 61 dayFebbo Phillip G.Chief Scientific & Med OfficerSSale−8.35K$36.02−$300.7K−8.3%92.4K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysLeite JohnChief Commercial Officer-CLIASSale−2.54K$35.00−$88.9K−2.8%89.1K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysMcGuire AnnieSVP, General CounselSSale−2.16K$35.00−$75.6K−2.4%89.4K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysEpstein Robert SDirectorSSale−21.5K$35.08−$753.3K−25.6%62.4K after10b5-1
Sep 23, 2025 (view filing)Sep 194 daysMcGuire AnnieSVP, General CounselSSale−2.28K$33.69−$76.9K−2.4%91.6K after10b5-1
Sep 8, 2025 (view filing)Sep 44 daysStapley MarcChief Executive OfficerSSale−7.67K$30.41−$233.2K−2.2%334.2K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysEastham KarinDirectorSSale−4.59K$26.66−$122.4K−24.8%13.9K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysBhanji MunaDirectorSSale−4.59K$26.67−$122.4K−13.3%30.0K after10b5-1
Jun 6, 2025 (view filing)Jun 42 daysLeite JohnChief Commercial Officer-CLIASSale−2.81K$27.20−$76.4K−2.9%94.5K after10b5-1
Mar 10, 2025 (view filing)Mar 73 daysLeite JohnChief Commercial Officer-CLIASSale−7.41K$31.66−$234.6K−6.9%100.2K after2 lots10b5-1
Mar 6, 2025 (view filing)Mar 42 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−8.04K$33.34−$268.0K−8.9%82.5K after2 lots10b5-1
Mar 6, 2025 (view filing)Mar 42 daysStapley MarcChief Executive OfficerSSale−52.7K$33.34−$1.76M−16.4%268.0K after3 lots10b5-1
Mar 6, 2025 (view filing)Mar 42 daysMcGuire AnnieSVP, General CounselSSale−1.14K$33.69−$38.5K−1.6%70.3K after10b5-1
Mar 3, 2025 (view filing)Feb 274 daysLeite JohnChief Commercial Officer-CLIASSale−5.75K$33.84−$194.4K−6.8%79.1K after
Feb 5, 2025 (view filing)Feb 32 daysChambers RebeccaChief Financial OfficerSSale−527$43.85−$23.1K−0.5%113.5K after10b5-1
Jan 6, 2025 (view filing)Jan 24 daysEastham KarinDirectorSSale−10.0K$40.30−$403.0K−35.1%18.5K after2 lots10b5-1
Dec 17, 2024 (view filing)Dec 134 daysStapley MarcChief Executive OfficerSSale−5.59K$43.43−$242.7K−1.8%307.3K after2 lots10b5-1